About Muazzam

Dr. Nasrullah, trained in Internal Medicine, and has a Master’s in Public Health from the renowned Karolinska Institute in Sweden. He earned his PhD in Epidemiology and Public Health in Germany. Currently, he is a Medical Officer at the U.S. Centers for Disease Control and Prevention (CDC), Division of Viral Hepatitis-Global Health where he is currently leading the activities of the Hepatitis C Elimination Program in the country of Georgia. Dr. Nasrullah also holds adjunct faculty appointments at Emory University’s Rollins School of Public Health and West Virginia University School of Public Health‘s Injury Control & Research Center. He is a former CDC Epidemic Intelligence Service (EIS) Officer, whose graduates are commonly referred to as "disease detectives."

Dr. Nasrullah has extensive experience in epidemiology, public health, surveillance, field investigations, project management and implementation at private, government, and academic settings in the United States, Europe, Africa and South Asia. Dr. Nasrullah has published extensively in the high-impact factor peer-reviewed journals. His research findings have been presented at renowned national and international conferences around the globe. Dr. Nasrullah serves on editorial boards and is a reviewer of several journals in Epidemiology and Public Health. He is a nominated member of the Eastern Mediterranean Association of Medical Editors, and holds memberships in several renowned organizations of Epidemiology and Public Health.

This speaker will be presenting at the following session(s)

  • The critical role of strategic information : HCV elimination in Georgia

    Parallel workshop

    Day: 1 November

    Time: 15:30

    Chair: Dr. Francisco Averhoff, Centers for Disease Control and Prevention

    Chair: Dr. Helen Harris, Public Health England

    Presentations:

    • Assessing the burden of disease: the planning, conduct and use of a National Seroprevalence Survey.
    • Dr. Amiran Gamkrelidze, National Center for Disease Control and Public Health of Georgia
    • Monitoring the care cascade: developing a robust screening and treatment information system.
    • Dr. Lia Gvinjilia, CDC Foundation for US Centers for Disease Control and Prevention
    • The role of research and project monitoring in HCV elimination.
    • Dr. Tinatin Kuchuloria, CDC Foundation for US Centers for Disease Control and Prevention
    • Modelling the epidemic to guide interventions.
    • Project oversight and guidance: the role of an independent Technical Advisory Group (TAG).
    • Dr. Muazzam Nasrullah, U.S. Centers for Disease Control and Prevention

    Session objectives:

    • Learn the importance of a well conducted population serosurvey to guide development of an evidence-based national strategy/plan.
    • Understand the importance of a robust strategic information system to guide and monitor an elimination program.
    • Learn the key role of partnerships in developing a world class information system.